SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)
$1.01 0.01 (1%)
Analysed SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) News Sources
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
24-03-2026
yahoo.com
Silexion Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
17-03-2026
yahoo.com
Silexion Therapeutics Urges Shareholders to Vote Ahead of March 16 Extraordinary General Meeting
05-03-2026
yahoo.com
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
21-01-2026
yahoo.com
Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026
06-01-2026
yahoo.com
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
16-12-2025
yahoo.com
Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
02-12-2025
yahoo.com
Silexion Therapeutics to Present at Noble Capital Markets' 21st Annual Emerging Growth Equity Conference
26-11-2025
yahoo.com
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
25-11-2025
yahoo.com
Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
12-11-2025
yahoo.com
What is the current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The current price of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is $1.01.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) absolute price change since previous trading day?
The absolute price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is $0.01.
SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) percentage price change since previous trading day?
The percentage price change of SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) since the previous trading day is 1%.
What is the most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent average sentiment score for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)?
The most recent sentiment for SILEXION THERAPEUTICS CORP (SLXN:NASDAQ) is .
SEC-8K** Filing Available For SILEXION THERAPEUTICS CORP (SLXN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.